Skip to content
DataLookout
Menu

GENSANCT04947059

Effectiveness of an Immediate Postoperative Intravesical Instillation With Either Gemcitabine or Epirubicin in Patients With Urinary Bladder Cancer (Gemcitabine Epirubicin Normal SAline)

StatusUnknown
PhasePhase 3
Primary completion (estimated)
Track this trial

Free. We email you which fields changed when ClinicalTrials.gov updates this record.

Record History

All 3 versions: 3 with changes below. See every version on ClinicalTrials.gov ↗

  1. Minor Changed Registry marked status Unknown (sponsor has not verified the record since Jan 2022); last known: Recruiting
  2. Notable Trial status: Not Yet Recruiting to Recruitingv3 Show 4 more changesShow less
    • Primary completion date: Oct 2024 to Oct 2025
    • Study completion date: Oct 2025 to Oct 2026
    • Start date changed from estimate of Oct 2021 to Dec 14, 2021
    • Site details revised
  3. Notable Primary endpoints revised (4)v2 Show 4 more changesShow less
    • Primary completion date: Sep 2024 to Oct 2024
    • Study completion date: Sep 2025 to Oct 2025
    • Start date: Sep 2021 to Oct 2021
    • Secondary endpoints revised (2)
  4. Study First Submitted
  • Notable: the plan changed
  • Minor: routine updates

Endpoints

Primary

Bladder cancer recurrence
Timeframe: At 3 months after the transurethral resection of a bladder tumor
Bladder cancer progression
Timeframe: At 3 months after the transurethral resection of a bladder tumor

Secondary (2)

Bladder cancer recurrence
Bladder cancer progression

Arms and interventions

GemcitabineActive comparator

Bladder cancer patients, who are treated with a transurethral resection of a bladder tumor, receive postoperatively, within 6 hours after the resection, an immediate single intravesical instillation with gemcitabine hydrochloride 2gr in 100ml of saline for 45-60 minutes and continuous saline irrigation for 24 hours

EpirubicinActive comparator

Bladder cancer patients, who are treated with a transurethral resection of a bladder tumor, receive postoperatively, within 6 hours after the resection, an immediate single intravesical instillation with epirubicine hydrochloride 50mg in 50ml of saline for 45-60 minutes and continuous saline irrigation for 24 hours

Drugs: Gemcitabine Hydrochloride combined with continuous saline irrigation, Epirubicin Hydrochloride combined with continuous saline irrigation

Sites

1 site in 1 country

  • Urology Department, University of Thessaly, University Hospital of LarissaLarissa, Larissa/Thessaly, Greece